These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 12183243

  • 1. In vitro and in vivo synergy of fosmidomycin, a novel antimalarial drug, with clindamycin.
    Wiesner J, Henschker D, Hutchinson DB, Beck E, Jomaa H.
    Antimicrob Agents Chemother; 2002 Sep; 46(9):2889-94. PubMed ID: 12183243
    [Abstract] [Full Text] [Related]

  • 2. Fosmidomycin for the treatment of malaria.
    Wiesner J, Borrmann S, Jomaa H.
    Parasitol Res; 2003 Jun; 90 Suppl 2():S71-6. PubMed ID: 12937969
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A second target of the antimalarial and antibacterial agent fosmidomycin revealed by cellular metabolic profiling.
    Zhang B, Watts KM, Hodge D, Kemp LM, Hunstad DA, Hicks LM, Odom AR.
    Biochemistry; 2011 May 03; 50(17):3570-7. PubMed ID: 21438569
    [Abstract] [Full Text] [Related]

  • 7. Fosmidomycin as an antimalarial drug: a meta-analysis of clinical trials.
    Fernandes JF, Lell B, Agnandji ST, Obiang RM, Bassat Q, Kremsner PG, Mordmüller B, Grobusch MP.
    Future Microbiol; 2015 May 03; 10(8):1375-90. PubMed ID: 26228767
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Fosmidomycin-clindamycin for the treatment of Plasmodium falciparum malaria.
    Borrmann S, Issifou S, Esser G, Adegnika AA, Ramharter M, Matsiegui PB, Oyakhirome S, Mawili-Mboumba DP, Missinou MA, Kun JF, Jomaa H, Kremsner PG.
    J Infect Dis; 2004 Nov 01; 190(9):1534-40. PubMed ID: 15478056
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Assessment of the pharmacokinetics and dynamics of two combination regimens of fosmidomycin-clindamycin in patients with acute uncomplicated falciparum malaria.
    Ruangweerayut R, Looareesuwan S, Hutchinson D, Chauemung A, Banmairuroi V, Na-Bangchang K.
    Malar J; 2008 Oct 31; 7():225. PubMed ID: 18973702
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Synthesis of alpha-substituted fosmidomycin analogues as highly potent Plasmodium falciparum growth inhibitors.
    Haemers T, Wiesner J, Van Poecke S, Goeman J, Henschker D, Beck E, Jomaa H, Van Calenbergh S.
    Bioorg Med Chem Lett; 2006 Apr 01; 16(7):1888-91. PubMed ID: 16439126
    [Abstract] [Full Text] [Related]

  • 18. Binding modes of reverse fosmidomycin analogs toward the antimalarial target IspC.
    Konzuch S, Umeda T, Held J, Hähn S, Brücher K, Lienau C, Behrendt CT, Gräwert T, Bacher A, Illarionov B, Fischer M, Mordmüller B, Tanaka N, Kurz T.
    J Med Chem; 2014 Nov 13; 57(21):8827-38. PubMed ID: 25254502
    [Abstract] [Full Text] [Related]

  • 19. The methylerythritol phosphate pathway is functionally active in all intraerythrocytic stages of Plasmodium falciparum.
    Cassera MB, Gozzo FC, D'Alexandri FL, Merino EF, del Portillo HA, Peres VJ, Almeida IC, Eberlin MN, Wunderlich G, Wiesner J, Jomaa H, Kimura EA, Katzin AM.
    J Biol Chem; 2004 Dec 10; 279(50):51749-59. PubMed ID: 15452112
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.